Final Combo Products cGMP Rule Contains Few Deviations From Draft

Devices & Diagnostics Letter
With few changes, the FDA has finalized a rule clarifying good manufacturing practice (GMP) requirements for single-entity and co-packaged drug-device products. The final rule, scheduled for publication in Tuesday’s Federal Register, takes effect on or about July 21.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00